| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.38 | 0.04 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.38 | 0.04 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |